GO:0033034 positive regulation of myeloid cell apoptotic process: Apoptosis Signaling, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033034 describes any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process, a programmed cell death pathway in myeloid lineage cells such as macrophages, neutrophils, monocytes, and myeloid-derived suppressor cells.
• Myeloid cell apoptosis is a central mechanism of immune homeostasis and is frequently dysregulated in cancer, sepsis, atherosclerosis, and inflammatory bowel disease.
• Key regulators include BRD4, which when inhibited drives MDSC apoptosis and enhances checkpoint blockade therapy, and Dectin-1, which modulates macrophage polarization and neutrophil infiltration in myocardial ischemia/reperfusion injury.
• Efferocytosis of apoptotic myeloid cells reprograms the tumor microenvironment and promotes pancreatic cancer liver metastasis, linking this GO term directly to metastatic progression.
• The aryl hydrocarbon receptor protects macrophages against pyroptosis and intestinal inflammation through polyamine biosynthesis, illustrating cross-talk between apoptotic and inflammatory cell death programs.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential tools for dissecting the causal roles of specific genes in positive regulation of myeloid cell apoptosis.
Description
GO:0033034, positive regulation of myeloid cell apoptotic process, is a biological process Gene Ontology term that captures any molecular event that activates or increases the frequency, rate, or extent of apoptosis in myeloid lineage cells. Myeloid cells, including macrophages, neutrophils, monocytes, dendritic cells, and myeloid-derived suppressor cells (MDSCs), are central effectors of innate immunity, and their lifespan is tightly controlled by apoptotic programs. Dysregulation of this process contributes to a broad spectrum of human diseases, from impaired antitumor immunity to chronic inflammatory conditions. Understanding the positive regulators of myeloid cell apoptosis is therefore critical for both basic immunology and therapeutic development. Recent studies have demonstrated that modulating myeloid cell apoptosis can have profound therapeutic consequences. For example, BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy, directly linking positive regulation of myeloid cell apoptosis to improved cancer immunotherapy outcomes. Similarly, irradiation combined with anti-PD-L1 treatment synergistically promotes antitumor immunity in mice, a process that involves myeloid cell dynamics. In the context of cardiovascular disease, Dectin-1 contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization and neutrophil infiltration, highlighting how myeloid cell survival decisions impact tissue damage. This article provides a research-grade synthesis of GO:0033034, covering its definition, mechanistic stages, key genes, disease relevance, and the CRISPR-based methods used to study it. All factual claims are grounded in peer-reviewed literature, and the content is optimized for both human researchers and generative AI retrieval systems seeking authoritative information on myeloid cell apoptosis regulation.
positive regulation of myeloid cell apoptotic process At A Glance
| GO ID | GO:0033034 |
|---|---|
| GO term | positive regulation of myeloid cell apoptotic process |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process. |
| Synonyms | activation of myeloid cell apoptosis; positive regulation of myeloid cell apoptosis; stimulation of myeloid cell apoptosis; up regulation of myeloid cell apoptosis; up-regulation of myeloid cell apoptosis; upregulation of myeloid cell apoptosis |
| Major function | Promotes programmed cell death in myeloid lineage cells, including macrophages, neutrophils, monocytes, and MDSCs, thereby regulating immune homeostasis and inflammation resolution. |
| Related processes | Apoptotic signaling, efferocytosis, pyroptosis, necroptosis, macrophage polarization, neutrophil infiltration |
| Disease relevance | Cancer immunotherapy, sepsis, atherosclerosis, myocardial ischemia/reperfusion injury, inflammatory bowel disease, pancreatic cancer metastasis |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, flow cytometry, RNA-seq, proteomics, library screening |
What Is GO:0033034?
GO:0033034 is defined by QuickGO as any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process. In practical terms, it encompasses the signaling events, transcriptional programs, and post-translational modifications that push myeloid lineage cells toward programmed cell death. This includes both intrinsic (mitochondrial) and extrinsic (death receptor) apoptotic pathways, as well as the upstream regulators that sensitize or trigger these pathways in macrophages, neutrophils, monocytes, and related cell types.
Why Is positive regulation of myeloid cell apoptotic process Important in Cell Biology?
Positive regulation of myeloid cell apoptosis is critically important because myeloid cells are key orchestrators of innate and adaptive immunity, and their timely removal by apoptosis is essential for resolving inflammation, preventing autoimmunity, and maintaining tissue homeostasis. When this process is impaired, myeloid cells such as MDSCs can accumulate and suppress antitumor immunity, whereas excessive myeloid apoptosis can exacerbate tissue injury and impair host defense. The therapeutic potential of targeting this process is exemplified by BRD4 inhibition, which induces MDSC apoptosis and enhances checkpoint blockade therapy, and by Dectin-1 modulation in myocardial ischemia/reperfusion injury. Thus, understanding the positive regulators of myeloid cell apoptosis offers opportunities for developing novel immunotherapies and anti-inflammatory strategies.
• Enhances antitumor immunity by promoting the elimination of immunosuppressive myeloid-derived suppressor cells (MDSCs).
• Regulates macrophage polarization and neutrophil infiltration in myocardial ischemia/reperfusion injury.
• Controls the resolution of inflammation through efferocytosis of apoptotic myeloid cells.
• Protects against intestinal inflammation by modulating macrophage pyroptosis and polyamine biosynthesis.
• Contributes to the pathogenesis of atherosclerosis through macrophage apoptosis, pyroptosis, and necroptosis.
• Is a determinant of sepsis outcomes via GITR-mediated regulation of macrophage pyroptosis.
• Provides a mechanistic basis for combining apoptosis-inducing agents with immune checkpoint blockade.
• Serves as a target for CRISPR-based functional genomics to identify novel regulators of myeloid cell death.
• Impacts pancreatic cancer liver metastasis through efferocytosis-driven reprogramming of the tumor microenvironment.
• Offers biomarkers and therapeutic targets for inflammatory and malignant diseases involving myeloid cells.
What Happens During positive regulation of myeloid cell apoptotic process?
Initiation of Apoptotic Signaling in Myeloid Cells
In simple terms: The process starts when a myeloid cell receives a signal that tells it to die.
Positive regulation of myeloid cell apoptosis begins with the activation of death receptors or intracellular stress pathways that sensitize myeloid cells to apoptosis. In macrophages, the aryl hydrocarbon receptor (AhR) can modulate polyamine biosynthesis to protect against pyroptosis, but when this protection is lost, apoptotic signaling can proceed. Similarly, Dectin-1 signaling in macrophages and neutrophils can shift the balance toward apoptosis during myocardial ischemia/reperfusion injury. These initiation events involve the integration of external cues, such as cytokines and pathogen-associated molecular patterns, with intrinsic cellular stress responses.
Mitochondrial Outer Membrane Permeabilization and Caspase Activation
In simple terms: The cell's powerhouses, the mitochondria, leak death signals that activate executioner enzymes.
Once the apoptotic decision is made, mitochondrial outer membrane permeabilization (MOMP) releases cytochrome c and other pro-apoptotic factors, leading to caspase-9 and downstream caspase-3/7 activation. In myeloid cells, this intrinsic pathway is regulated by the Bcl-2 family of proteins. Macrophage-derived galectin-3 has been shown to contribute to apoptosis, pyroptosis, and necroptosis through the TLR4/MyD88/NF-κB/NLRP3 axis during atherosclerosis, indicating that inflammatory signaling can directly engage mitochondrial apoptotic machinery. BRD4 inhibition in MDSCs also triggers apoptosis, likely through transcriptional downregulation of anti-apoptotic proteins.
Efferocytosis and Clearance of Apoptotic Myeloid Cells
In simple terms: After the cell dies, it is eaten by neighboring cells in a process called efferocytosis.
The positive regulation of myeloid cell apoptosis is not complete until the dying cell is recognized and cleared by phagocytes, a process known as efferocytosis. Efferocytosis of apoptotic myeloid cells reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis, demonstrating that the consequences of myeloid apoptosis extend beyond cell death to tissue remodeling and metastasis. This step involves the exposure of phosphatidylserine on the apoptotic cell surface and its recognition by receptors such as MerTK and Axl on macrophages.
Cross-talk with Pyroptosis and Necroptosis Pathways
In simple terms: Apoptosis is not the only way myeloid cells die; it talks to other death programs.
Positive regulation of myeloid cell apoptosis often intersects with pyroptosis and necroptosis, particularly in inflammatory contexts. GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3, showing that apoptotic and pyroptotic regulators can be co-opted. Similarly, galectin-3 drives apoptosis, pyroptosis, and necroptosis through TLR4/MyD88/NF-κB/NLRP3 during atherosclerosis. These cross-talk mechanisms are critical for understanding how myeloid cell death shapes disease outcomes.
Transcriptional and Post-translational Control of Myeloid Apoptosis
In simple terms: Genes and proteins can be turned up or down to control whether a myeloid cell dies.
The positive regulation of myeloid cell apoptosis is controlled at multiple levels, including transcription factors such as c-Myb, which is expressed in prenatal odontogenesis and may influence myeloid cell survival. BRD4 inhibition leads to MDSC apoptosis, indicating that epigenetic readers can transcriptionally reprogram survival pathways. Post-translational modifications, such as ubiquitination and phosphorylation, also regulate the stability and activity of apoptotic effectors like NLRP3 and caspase-1. These layers of control provide numerous entry points for therapeutic intervention.
Key Genes Involved in GO:0033034 positive regulation of myeloid cell apoptotic process
The following genes and proteins have been experimentally implicated in the positive regulation of myeloid cell apoptotic process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BRD4 | Epigenetic reader that promotes MDSC survival; its inhibition induces apoptosis | Target for enhancing checkpoint blockade therapy |
| Dectin-1 | Pattern recognition receptor regulating macrophage polarization and neutrophil infiltration | Modulates myocardial ischemia/reperfusion injury |
| AhR | Aryl hydrocarbon receptor regulating polyamine biosynthesis and macrophage pyroptosis | Protects against intestinal inflammation |
| GITR | Glucocorticoid-induced TNFR-related protein regulating NLRP3 posttranslationally | Exacerbates macrophage pyroptosis in sepsis |
| Galectin-3 | Macrophage-derived lectin driving apoptosis, pyroptosis, and necroptosis | Contributes to atherosclerosis via TLR4/MyD88/NF-κB/NLRP3 |
| NLRP3 | Inflammasome sensor mediating pyroptosis and cross-talk with apoptosis | Central node in inflammatory cell death |
| TLR4 | Toll-like receptor 4 initiating inflammatory signaling | Upstream of galectin-3-mediated death in atherosclerosis |
| MyD88 | Adaptor protein for TLR signaling | Mediates NF-κB activation in apoptotic/pyroptotic pathways |
| NF-κB | Transcription factor regulating survival and inflammatory genes | Modulates apoptosis and pyroptosis balance |
| c-Myb | Transcription factor involved in cell proliferation and survival | Expressed in prenatal odontogenesis; potential regulator of myeloid survival |
| PD-L1 | Immune checkpoint ligand; anti-PD-L1 synergizes with irradiation | Promotes antitumor immunity involving myeloid cells |
| MerTK | Efferocytosis receptor on macrophages | Recognizes apoptotic cells and reprograms tumor microenvironment |
| Axl | Efferocytosis receptor tyrosine kinase | Facilitates clearance of apoptotic myeloid cells |
| Caspase-3 | Executioner caspase in apoptosis | Downstream effector of myeloid cell apoptosis |
| Caspase-9 | Initiator caspase in intrinsic apoptosis | Activated upon MOMP in myeloid cells |
| Bcl-2 | Anti-apoptotic protein | Regulates mitochondrial outer membrane permeabilization |
| Bax | Pro-apoptotic protein | Promotes MOMP and cytochrome c release |
How Is positive regulation of myeloid cell apoptotic process Regulated?
The positive regulation of myeloid cell apoptotic process is controlled by a complex network of transcriptional, post-translational, and epigenetic mechanisms. BRD4 inhibition transcriptionally reprograms MDSCs toward apoptosis, demonstrating epigenetic control. The aryl hydrocarbon receptor regulates polyamine biosynthesis to protect macrophages against pyroptosis, indirectly influencing apoptotic thresholds. GITR posttranslationally regulates NLRP3, linking costimulatory signals to inflammasome-mediated death. Additionally, galectin-3 activates the TLR4/MyD88/NF-κB/NLRP3 axis to drive apoptosis, pyroptosis, and necroptosis in atherosclerosis. These regulatory layers provide multiple targets for therapeutic modulation of myeloid cell lifespan.
positive regulation of myeloid cell apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRD4 | Cancer immunotherapy resistance | MDSC-specific BRD4 knockout or overexpression in mouse tumor models |
| Dectin-1 | Myocardial ischemia/reperfusion injury | Dectin-1 knockout mice subjected to coronary ligation/reperfusion |
| AhR | Inflammatory bowel disease | AhR knockout or conditional knock-in in intestinal macrophages |
| GITR | Sepsis | GITR knockout mice with LPS-induced sepsis |
| Galectin-3 | Atherosclerosis | Galectin-3 knockout or overexpression in ApoE-/- mice |
Cancer and Immunotherapy
Positive regulation of myeloid cell apoptosis is directly relevant to cancer immunotherapy. BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy, showing that inducing apoptosis in immunosuppressive myeloid cells can overcome resistance to immune checkpoint inhibitors. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice, a process that involves myeloid cell dynamics. Furthermore, efferocytosis of apoptotic myeloid cells reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis, indicating that the consequences of myeloid apoptosis can be either beneficial or detrimental depending on context.
Cardiovascular Disease
In myocardial ischemia/reperfusion injury, Dectin-1 contributes to injury by regulating macrophage polarization and neutrophil infiltration, processes that involve myeloid cell apoptosis. Macrophage-derived galectin-3 drives apoptosis, pyroptosis, and necroptosis through the TLR4/MyD88/NF-κB/NLRP3 axis during atherosclerosis, highlighting the role of myeloid cell death in plaque instability and cardiovascular events.
Sepsis and Inflammatory Bowel Disease
GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3, linking positive regulation of myeloid cell death to septic organ injury. In intestinal inflammation, the aryl hydrocarbon receptor confers protection against macrophage pyroptosis through polyamine biosynthesis, suggesting that modulating myeloid cell death pathways can maintain intestinal homeostasis.
From positive regulation of myeloid cell apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BRD4 loss induce MDSC apoptosis? | BRD4 knockout in MDSCs using CRISPR |
| Does a point mutation in NLRP3 affect macrophage pyroptosis? | NLRP3 point-mutation knock-in mice |
| Does Dectin-1 overexpression alter neutrophil infiltration? | Dectin-1 overexpression in macrophages |
| Does AhR regulate polyamine biosynthesis in macrophages? | AhR knockout and knock-in models |
| Does galectin-3 drive apoptosis in atherosclerosis? | Galectin-3 knockout in ApoE-/- mice |
| Does c-Myb regulate myeloid survival? | c-Myb conditional knockout in myeloid lineage |
How to Study the positive regulation of myeloid cell apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry (Annexin V/PI) | Apoptotic and necrotic cell frequency | Quantifying MDSC apoptosis after BRD4 inhibition |
| RNA-seq | Transcriptional changes | Identifying genes upregulated during myeloid apoptosis |
| ATAC-seq | Chromatin accessibility | Mapping epigenetic changes in apoptotic myeloid cells |
| Proteomics | Protein abundance and modifications | Detecting NLRP3 posttranslational regulation |
| CRISPR knockout screening | Gene essentiality for apoptosis | Discovering novel regulators of myeloid cell death |
| Immunohistochemistry | Tissue localization of apoptotic markers | Detecting apoptosis in atherosclerotic plaques |
| Efferocytosis assay | Clearance of apoptotic cells | Measuring macrophage efferocytosis in tumor microenvironment |
| Caspase activity assay | Caspase-3/7/9 activity | Confirming intrinsic apoptosis pathway activation |
Flow Cytometry and Apoptosis Assays
Flow cytometry with Annexin V/PI staining is the gold standard for quantifying apoptosis in myeloid cells. This method allows researchers to distinguish early apoptotic, late apoptotic, and necrotic cells, and can be combined with surface markers to identify specific myeloid subsets such as MDSCs or macrophages. TUNEL staining and caspase activity assays provide complementary readouts.
Transcriptomics and Epigenomics
RNA-seq and ATAC-seq can reveal transcriptional and epigenetic changes that accompany positive regulation of myeloid cell apoptosis. For example, BRD4 inhibition in MDSCs leads to widespread transcriptional changes that precede apoptosis, which can be mapped by RNA-seq. Single-cell RNA-seq enables the dissection of heterogeneous myeloid populations undergoing apoptosis in complex tissues.
Proteomics and Post-translational Modification Analysis
Mass spectrometry-based proteomics can identify post-translational modifications such as ubiquitination and phosphorylation on apoptotic regulators. GITR-mediated regulation of NLRP3 involves posttranslational modifications that can be detected by immunoprecipitation followed by mass spectrometry. Phosphoproteomics can uncover signaling nodes that drive myeloid cell apoptosis.
CRISPR Library Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens are powerful tools for identifying novel positive regulators of myeloid cell apoptosis. By selecting for cells that survive or die under apoptotic stimuli, researchers can uncover genes that regulate this process. These screens can be performed in primary myeloid cells or cell lines and validated with individual knockouts.
How CRISPR Can Be Used to Study GO:0033034 positive regulation of myeloid cell apoptotic process
Knockout
CRISPR knockout is used to delete candidate genes and determine whether they are required for positive regulation of myeloid cell apoptosis. For example, knocking out BRD4 in MDSCs can test whether BRD4 is essential for their survival, and whether its loss induces apoptosis. Similarly, Dectin-1 knockout mice have been used to study macrophage polarization and neutrophil infiltration in myocardial ischemia/reperfusion injury.
Point Mutation
Point mutations can be introduced to dissect specific residues required for apoptotic signaling. For instance, mutating phosphorylation sites on NLRP3 can reveal how GITR-mediated posttranslational regulation affects macrophage pyroptosis. Point mutations in Bcl-2 family proteins can also clarify their role in mitochondrial outer membrane permeabilization during myeloid apoptosis.
Knock-in
Knock-in models allow the expression of tagged or reporter proteins to track apoptotic cells in vivo. A fluorescent reporter knocked into a myeloid-specific locus can enable real-time imaging of apoptosis in tissues. Knock-in of human disease-associated variants, such as those in galectin-3, can model atherosclerosis susceptibility.
Overexpression
Overexpression of pro-apoptotic genes or constitutively active mutants can drive myeloid cell apoptosis and test sufficiency. For example, overexpressing galectin-3 in macrophages can induce apoptosis, pyroptosis, and necroptosis through the TLR4/MyD88/NF-κB/NLRP3 axis. Overexpression of AhR can protect against macrophage pyroptosis by enhancing polyamine biosynthesis.
How EDITGENE Supports positive regulation of myeloid cell apoptotic process Research
Researchers studying positive regulation of myeloid cell apoptotic process-related genes often need to determine whether a candidate gene is causally involved in myeloid cell death, and whether its manipulation can alter disease outcomes. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from generating knockout and point-mutation cell models to performing genome-wide library screens and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of myeloid cell apoptotic process research.
Frequently Asked Questions About positive regulation of myeloid cell apoptotic process
What is GO:0033034?
GO:0033034 is the Gene Ontology term for positive regulation of myeloid cell apoptotic process, defined as any process that activates or increases the frequency, rate, or extent of apoptosis in myeloid cells such as macrophages, neutrophils, and MDSCs.
What genes are involved in positive regulation of myeloid cell apoptotic process?
Key genes include BRD4, Dectin-1, AhR, GITR, galectin-3, NLRP3, TLR4, MyD88, NF-κB, and c-Myb, among others.
How is myeloid cell apoptosis regulated?
It is regulated by transcriptional, post-translational, and epigenetic mechanisms, including BRD4-mediated transcription, AhR-dependent polyamine biosynthesis, and GITR-mediated NLRP3 modification.
Why is positive regulation of myeloid cell apoptosis important in cancer?
Inducing apoptosis in immunosuppressive myeloid cells such as MDSCs can enhance checkpoint blockade therapy and antitumor immunity.
What diseases are associated with dysregulated myeloid cell apoptosis?
Cancer, sepsis, atherosclerosis, myocardial ischemia/reperfusion injury, inflammatory bowel disease, and pancreatic cancer metastasis.
What methods are used to study positive regulation of myeloid cell apoptosis?
Flow cytometry, RNA-seq, ATAC-seq, proteomics, CRISPR screens, and efferocytosis assays are commonly used.
How does BRD4 inhibition affect myeloid cells?
BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy, making it a promising therapeutic strategy.
What is the role of efferocytosis in myeloid cell apoptosis?
Efferocytosis clears apoptotic myeloid cells and can reprogram the tumor microenvironment to promote pancreatic cancer liver metastasis.
Can CRISPR be used to study myeloid cell apoptosis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in myeloid cell apoptosis.
What is the difference between apoptosis and pyroptosis in myeloid cells?
Apoptosis is a non-inflammatory programmed cell death, while pyroptosis is inflammatory and often mediated by inflammasomes like NLRP3; the two pathways can cross-talk.
Conclusion
GO:0033034, positive regulation of myeloid cell apoptotic process, is a fundamental biological process that governs the lifespan of myeloid cells and shapes immune responses in health and disease. From enhancing antitumor immunity by eliminating MDSCs to modulating tissue injury in cardiovascular disease, the regulators of this process offer numerous therapeutic opportunities. Continued research using CRISPR-based models and multi-omics approaches will further unravel the complex mechanisms controlling myeloid cell apoptosis. EDITGENE is committed to supporting this research with state-of-the-art CRISPR services, including knockout, point-mutation, knock-in, overexpression, and library screening, enabling researchers to causally link specific genes to positive regulation of myeloid cell apoptosis and to translate these findings into novel therapies.
References
- 1. Deng L et al.. 2014. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.. J Clin Invest 124(2):687-95 PMID: 24382348
- 2. Astuti Y et al.. 2024. Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.. Nat Cancer 5(5):774-790 PMID: 38355776
- 3. Gao Y et al.. 2024. Aryl hydrocarbon receptor confers protection against macrophage pyroptosis and intestinal inflammation through regulating polyamine biosynthesis.. Theranostics 14(11):4218-4239 PMID: 39113799
- 4. Fan Q et al.. 2019. Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.. Circulation 139(5):663-678 PMID: 30586706
- 5. Savardekar H et al.. 2025. BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy.. J Clin Invest 135(19) PMID: 40762981
- 6. Liang S et al.. 2024. GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3.. Cell Mol Immunol 21(7):674-688 PMID: 38740925
- 7. Yuan Z et al.. 2026. Macrophage-derived galectin-3 contributes to pyroptosis, apoptosis and necroptosis through TLR4/MyD88/NF-κB/NLRP3 during atherosclerosis.. Clin Transl Med 16(3):e70637 PMID: 41795807
- 8. Matalová E et al.. 2011. Expression and characterization of c-Myb in prenatal odontogenesis.. Dev Growth Differ 53(6):793-803 PMID: 21762405
